{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:28:06Z","timestamp":1793204886805,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":1441,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["01ED1202A"],"award-info":[{"award-number":["01ED1202A"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["01ED1203F"],"award-info":[{"award-number":["01ED1203F"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["246513"],"award-info":[{"award-number":["246513"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["633190"],"award-info":[{"award-number":["633190"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["O1GI1007A"],"award-info":[{"award-number":["O1GI1007A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1103A"],"award-info":[{"award-number":["01GM1103A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Baden-W?rttemberg Stiftung","award":["D.3830"],"award-info":[{"award-number":["D.3830"]}]},{"name":"Boehringer Ingelheim Ulm University BioCenter (BIU)","award":["D.5009"],"award-info":[{"award-number":["D.5009"]}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1074\/mcp.m116.059915","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T23:03:13Z","timestamp":1470783793000},"page":"3126-3138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer\u2032s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies"],"prefix":"10.1016","volume":"15","author":[{"given":"Patrick","family":"Oeckl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Nagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.F.","family":"von Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Halbgebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Steinacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M116.059915_bib1","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","article-title":"\u03b1-Synucleinopathy phenotypes","volume":"20","author":"McCann","year":"2014","journal-title":"Parkinsonism Relat. Disord"},{"key":"10.1074\/mcp.M116.059915_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12035-012-8330-5","article-title":"\u03b1-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration","volume":"47","author":"Beyer","year":"2013","journal-title":"Mol. Neurobiol"},{"key":"10.1074\/mcp.M116.059915_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1074\/mcp.M116.059915_bib4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"FASEB J"},{"key":"10.1074\/mcp.M116.059915_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/bmm.15.107","article-title":"Value of cerebrospinal fluid \u03b1-synuclein species as biomarker in Parkinson's diagnosis and prognosis","volume":"10","author":"Parnetti","year":"2016","journal-title":"Biomark. Med"},{"key":"10.1074\/mcp.M116.059915_bib6","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","article-title":"Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein","volume":"96","author":"Galvin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M116.059915_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","article-title":"beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor","volume":"32","author":"Hashimoto","year":"2001","journal-title":"Neuron"},{"key":"10.1074\/mcp.M116.059915_bib8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/hmg\/ddp090","article-title":"Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein","volume":"18","author":"Ninkina","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/mcp.M116.059915_bib9","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1074\/mcp.M114.038554","article-title":"In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR)","volume":"13","author":"Guldbrandsen","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.059915_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000141039","article-title":"Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes","volume":"26","author":"Mukaetova-Ladinska","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1074\/mcp.M116.059915_bib11","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1074\/mcp.M700163-MCP200","article-title":"Isotope-labeled protein standards: toward absolute quantitative proteomics","volume":"6","author":"Brun","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.059915_bib12","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/pr5006058","article-title":"Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer\u2032s disease and frontotemporal lobar degeneration","volume":"13","author":"Oeckl","year":"2014","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.059915_bib13","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1074\/mcp.R113.032730","article-title":"Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies","volume":"12","author":"Schmid","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.059915_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/acs.jproteome.5b01001","article-title":"Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity","volume":"15","author":"Barth\u00e9lemy","year":"2016","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.059915_bib15","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc"},{"key":"10.1074\/mcp.M116.059915_bib16","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1074\/mcp.M116.059915_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1074\/mcp.M116.059915_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1074\/mcp.M116.059915_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord"},{"key":"10.1074\/mcp.M116.059915_bib20","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1074\/mcp.M116.059915_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1074\/mcp.M116.059915_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1074\/mcp.M116.059915_bib23","unstructured":".World Health Organization (1998) Consensus on criteria for sporadic CJD."},{"key":"10.1074\/mcp.M116.059915_bib24","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00415-010-5876-x","article-title":"Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases","volume":"258","author":"Jesse","year":"2011","journal-title":"J. Neurol"},{"key":"10.1074\/mcp.M116.059915_bib25","series-title":"New Concepts of a Blood\u2014Brain Barrier (Springer)","first-page":"209","author":"Felgenhauer","year":"1995"},{"key":"10.1074\/mcp.M116.059915_bib26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bpj.2009.12.4290","article-title":"Early aggregation steps in alpha-synuclein as measured by FCS and FRET: evidence for a contagious conformational change","volume":"98","author":"Nath","year":"2010","journal-title":"Biophys. J"},{"key":"10.1074\/mcp.M116.059915_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1110\/ps.051867106","article-title":"Temperature-induced reversible conformational change in the first 100 residues of alpha-synuclein","volume":"15","author":"McNulty","year":"2006","journal-title":"Protein Sci"},{"key":"10.1074\/mcp.M116.059915_bib28","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1110\/ps.24301","article-title":"Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c","volume":"10","author":"Morar","year":"2001","journal-title":"Protein Sci"},{"key":"10.1074\/mcp.M116.059915_bib29","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1074\/mcp.M116.059915_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mds.26635","article-title":"Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins","volume":"31","author":"Halbgebauer","year":"2016","journal-title":"Mov. Disord"},{"key":"10.1074\/mcp.M116.059915_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201500449","article-title":"Advances in targeted proteomics and applications to biomedical research","author":"Shi","year":"2016","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M116.059915_bib32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/mcp.M113.036095","article-title":"Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach","volume":"13","author":"Carr","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.059915_bib33","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00415-015-7837-x","article-title":"Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD","volume":"262","author":"Llorens","year":"2015","journal-title":"J. Neurol"},{"key":"10.1074\/mcp.M116.059915_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/nan.12175","article-title":"Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease","volume":"41","author":"Llorens","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"10.1074\/mcp.M116.059915_bib35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00415-014-7334-7","article-title":"Increased \u03b1-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"261","author":"Kasai","year":"2014","journal-title":"J. Neurol"},{"key":"10.1074\/mcp.M116.059915_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp. Neurol"},{"key":"10.1074\/mcp.M116.059915_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimers. Res. Ther"},{"key":"10.1074\/mcp.M116.059915_bib38","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/j.jalz.2013.10.004","article-title":"Increased CSF \u03b1-synuclein levels in Alzheimer's disease: correlation with tau levels","volume":"10","author":"Slaets","year":"2014","journal-title":"Alzheimers. Dement"},{"key":"10.1074\/mcp.M116.059915_bib39","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch. Neurol"},{"key":"10.1074\/mcp.M116.059915_bib40","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.neurobiolaging.2015.05.003","article-title":"Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study","volume":"36","author":"Kruse","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/mcp.M116.059915_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2015.08.003","article-title":"Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human \u03b1-Synuclein in cerebrospinal fluid","volume":"426","author":"Kruse","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/mcp.M116.059915_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fneur.2015.00179","article-title":"A Practical Guide to Immunoassay Method Validation","volume":"6","author":"Andreasson","year":"2015","journal-title":"Front. Neurol"},{"key":"10.1074\/mcp.M116.059915_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-60761-938-3_4","article-title":"The blood-cerebrospinal fluid barrier: structure and functional significance","volume":"686","author":"Johanson","year":"2011","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/mcp.M116.059915_bib44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737159.8.4.479","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases","volume":"8","author":"Tumani","year":"2008","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1074\/mcp.M116.059915_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis"},{"key":"10.1074\/mcp.M116.059915_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00702-012-0784-0","article-title":"\u03b1-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system","volume":"119","author":"Mollenhauer","year":"2012","journal-title":"J. Neural Transm"},{"key":"10.1074\/mcp.M116.059915_bib47","doi-asserted-by":"crossref","unstructured":".Bates, C. A., Fu, S., Ysselstein, D., Rochet, J.-C., and Zheng, W., Expression and Transport of \u03b1-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese Exposure. ADMET DMPK 3, 15\u201333,","DOI":"10.5599\/admet.3.1.159"},{"key":"10.1074\/mcp.M116.059915_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-015-0185-3","article-title":"Phosphorylated \u03b1-synuclein in Parkinson's disease: correlation depends on disease severity","volume":"3","author":"Stewart","year":"2015","journal-title":"Acta Neuropathol. Commun"},{"key":"10.1074\/mcp.M116.059915_bib49","doi-asserted-by":"crossref","first-page":"121ra20","DOI":"10.1126\/scitranslmed.3002566","article-title":"Phosphorylated \u03b1-synuclein in Parkinson's disease","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/mcp.M116.059915_bib50","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.059915_bib51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.059915_bib52","doi-asserted-by":"crossref","first-page":"33250","DOI":"10.1074\/jbc.M606147200","article-title":"Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation","volume":"281","author":"Kim","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.059915_bib53","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","article-title":"Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions","volume":"30","author":"Paleologou","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1074\/mcp.M116.059915_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2337\/db08-0994","article-title":"Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes","volume":"58","author":"Wang","year":"2009","journal-title":"Diabetes"},{"key":"10.1074\/mcp.M116.059915_bib55","doi-asserted-by":"crossref","first-page":"34472","DOI":"10.1074\/jbc.R114.601351","article-title":"The emerging link between O-GlcNAc and Alzheimer disease","volume":"289","author":"Zhu","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.059915_bib56","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.celrep.2013.07.024","article-title":"Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation","volume":"4","author":"Weinert","year":"2013","journal-title":"Cell Rep"},{"key":"10.1074\/mcp.M116.059915_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1074\/mcp.O112.018366","article-title":"Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse","volume":"11","author":"Trinidad","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.059915_bib58","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M116.059915_bib59","doi-asserted-by":"crossref","first-page":"e103727","DOI":"10.1371\/journal.pone.0103727","article-title":"N-alpha-acetylation of \u03b1-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation","volume":"9","author":"Bartels","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.M116.059915_bib60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers. Dement"},{"key":"10.1074\/mcp.M116.059915_bib61","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nature13319","article-title":"Mass-spectrometry-based draft of the human proteome","volume":"509","author":"Wilhelm","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.059915_bib62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"Kim","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.059915_bib63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann. Neurol"},{"key":"10.1074\/mcp.M116.059915_bib64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/01.WNL.0000139870.14385.3C","article-title":"Beta-synuclein gene alterations in dementia with Lewy bodies","volume":"63","author":"Ohtake","year":"2004","journal-title":"Neurology"},{"key":"10.1074\/mcp.M116.059915_bib65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ncomms1101","article-title":"A \u03b2-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain","volume":"1","author":"Fujita","year":"2010","journal-title":"Nat. Commun"},{"key":"10.1074\/mcp.M116.059915_bib66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","article-title":"Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease","volume":"349","author":"Tokuda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/mcp.M116.059915_bib67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jneumeth.2007.09.021","article-title":"A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid","volume":"168","author":"van Geel","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1074\/mcp.M116.059915_bib68","doi-asserted-by":"crossref","first-page":"e22225","DOI":"10.1371\/journal.pone.0022225","article-title":"Assessment of \u03b1-synuclein secretion in mouse and human brain parenchyma","volume":"6","author":"Emmanouilidou","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.M116.059915_bib69","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymeth.2012.03.016","article-title":"Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of \u03b1-synuclein and other proteins in cerebrospinal fluid","volume":"56","author":"Kruse","year":"2012","journal-title":"Methods"},{"key":"10.1074\/mcp.M116.059915_bib70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2012.11.004","article-title":"Total CSF \u03b1-synuclein is lower in de novo Parkinson patients than in healthy subjects","volume":"532","author":"Mollenhauer","year":"2013","journal-title":"Neurosci. Lett"},{"key":"10.1074\/mcp.M116.059915_bib71","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/BF01466734","article-title":"Protein size and cerebrospinal fluid composition","volume":"52","author":"Felgenhauer","year":"1974","journal-title":"Klin. Wochenschr"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762033348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762033348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M116.059915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:45:26Z","timestamp":1761525926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153594762033348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S153594762033348X"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m116.059915","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer\u2032s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M116.059915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}